1. Home
  2. PRPH vs NXGL Comparison

PRPH vs NXGL Comparison

Compare PRPH & NXGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPH
  • NXGL
  • Stock Information
  • Founded
  • PRPH 1989
  • NXGL 1997
  • Country
  • PRPH United States
  • NXGL United States
  • Employees
  • PRPH N/A
  • NXGL N/A
  • Industry
  • PRPH Biotechnology: Pharmaceutical Preparations
  • NXGL Medical/Dental Instruments
  • Sector
  • PRPH Health Care
  • NXGL Health Care
  • Exchange
  • PRPH Nasdaq
  • NXGL Nasdaq
  • Market Cap
  • PRPH 17.7M
  • NXGL 19.7M
  • IPO Year
  • PRPH 1997
  • NXGL 2021
  • Fundamental
  • Price
  • PRPH $0.28
  • NXGL $2.65
  • Analyst Decision
  • PRPH
  • NXGL
  • Analyst Count
  • PRPH 0
  • NXGL 0
  • Target Price
  • PRPH N/A
  • NXGL N/A
  • AVG Volume (30 Days)
  • PRPH 1.1M
  • NXGL 56.4K
  • Earning Date
  • PRPH 08-13-2025
  • NXGL 08-12-2025
  • Dividend Yield
  • PRPH N/A
  • NXGL N/A
  • EPS Growth
  • PRPH N/A
  • NXGL N/A
  • EPS
  • PRPH N/A
  • NXGL N/A
  • Revenue
  • PRPH $5,845,000.00
  • NXGL $10,228,000.00
  • Revenue This Year
  • PRPH $221.82
  • NXGL $52.35
  • Revenue Next Year
  • PRPH N/A
  • NXGL $42.38
  • P/E Ratio
  • PRPH N/A
  • NXGL N/A
  • Revenue Growth
  • PRPH N/A
  • NXGL 116.01
  • 52 Week Low
  • PRPH $0.22
  • NXGL $2.10
  • 52 Week High
  • PRPH $3.00
  • NXGL $5.10
  • Technical
  • Relative Strength Index (RSI)
  • PRPH 35.31
  • NXGL 56.14
  • Support Level
  • PRPH $0.30
  • NXGL $2.43
  • Resistance Level
  • PRPH $0.35
  • NXGL $2.71
  • Average True Range (ATR)
  • PRPH 0.04
  • NXGL 0.20
  • MACD
  • PRPH -0.01
  • NXGL 0.03
  • Stochastic Oscillator
  • PRPH 1.93
  • NXGL 84.03

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

About NXGL NexGel Inc

NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.

Share on Social Networks: